IDEXX Laboratories, Inc. (IDXX) vs Mastercard Incorporated (MA)
A side-by-side comparison of IDEXX Laboratories, Inc. and Mastercard Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.
Different business models: IDXX is classified in Healthcare; MA is classified in Financial Services. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
IDXX
IDEXX Laboratories, Inc.
$504.70HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
MA
Mastercard Incorporated
$569.19Financial ServicesDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — IDXX vs MA
growth of $100 · dividends reinvested · last 10yIDXX +344.5% (+16.1%/yr)MA +498.8% (+19.6%/yr)MA compounded faster over this window
IDXX MA
IDXX vs MA: by the numbers
- •MA is the larger company ($499.20B vs $39.81B market cap).
- •MA trades at the lower trailing earnings multiple (31.31 vs 35.74 P/E), one valuation lens rather than an overall verdict.
- •MA converts more revenue to profit (46.34% vs 25.03% net margin).
- •MA grew revenue faster over the past five years (16.09% vs 8.37% CAGR).
- •MA pays a dividend (0.60% yield), while IDXX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | IDXX | MA |
|---|---|---|
| P/E ratio | 35.74 | 31.31 |
| Forward P/E | 34.17 | 28.52 |
| P/S ratio | 8.74 | 14.23 |
| P/B ratio | 24.69 | 88.97 |
| EV / EBITDA | 25.24 | N/A |
| FCF yield | 3.14% | N/A |
Profitability
| Metric | IDXX | MA |
|---|---|---|
| Gross margin | 62.45% | 100.00% |
| Operating margin | 32.03% | 59.84% |
| Net margin | 25.03% | 46.34% |
| ROE | 70.67% | 289.73% |
| ROIC | 41.33% | N/A |
Dividends
| Metric | IDXX | MA |
|---|---|---|
| Dividend yield | N/A | 0.60% |
| Payout ratio | N/A | 18.54% |
Growth (annualized)
| Metric | IDXX | MA |
|---|---|---|
| Revenue CAGR (5Y) | 8.37% | 16.09% |
| EPS CAGR (5Y) | 14.07% | 20.93% |
| FCF CAGR (5Y) | 12.49% | N/A |
| Total return CAGR (5Y) | -5.77% | 10.88% |
Frequently asked
- Which has the lower trailing P/E, IDXX or MA?
- MA has the lower trailing P/E: IDXX trades at 35.74 and MA at 31.31. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, IDXX or MA?
- Over the past five years, MA grew revenue faster — IDXX at a 8.37% CAGR versus MA at 16.09%.
- Does IDXX or MA pay a bigger dividend?
- MA pays a dividend (0.60% yield), while IDXX has no payments in the available dividend history.
- Is IDXX or MA more profitable?
- MA runs the higher net margin — IDXX at 25.03% versus MA at 46.34%.
- How have IDXX and MA total returns compared?
- Over the past 10 years, IDXX delivered 16.50% and MA delivered 19.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
IDEXX Laboratories P/E ratioMastercard P/E ratioMastercard dividend yieldIDEXX Laboratories ROEMastercard ROEIDEXX Laboratories operating marginMastercard operating marginIDEXX Laboratories revenue growthMastercard revenue growthIDEXX Laboratories free cash flow
IDEXX Laboratories & Mastercard appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.